Pricing

89bio, Inc (ETNB)

followers ยท
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Rohan Palekar
Employees: 40
Web site: 89bio.com
655 MONTGOMERY STREET, SUITE 1500, SAN FRANCISCO, CA, 94111
(415) 432-9270
All 13F Filers Prior Change Hedge Funds 1 Prior Change
89bio, Inc. focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available